TEVA TO COLLABORATE WITH NST ON CANCER TREATMENT

Teva Pharmaceutical Industries Ltd. has signed a strategic cooperation agreement with NeuroSurvival Technologies (NST) of Petah Tikva for the development of a new treatment for cancer. The technology is based on the development of new molecular complexes, in turn based on original technology developed by NST, called ApoSense.

Globes Online (http://www.globes.co.il/serveen/globes/docview.asp?did=1000067731&fid=942)